+
RA-Value-Dividend
Bullish screener rule firing in the current setup window.
Strength
High
Weight
80%
Impact
High
Hits
2
REGN
RegeneronBNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Earnings surprise screen
25Disqualified2026-10-30 bmo
Regeneron's official calendar confirms the October 30 report and its prior-quarter release describes commercial-product momentum, but the checked sources do not establish current-quarter positive revisions or revenue upside; recent tape and volume confirmation are also incomplete, so the required pre-event setup is not demonstrated.
Revision
0
Revenue
0
Business
12
Price
5
Volume
0
Risk
8
Required signals: None marked positive
Preferred signals: None marked positive
Risk flags: no consensus eps or revenue source
Screen as of 2026-10-28. Window 2026-10-28 to 2026-11-03.
Setup hits (3d)
Net Bullish
8 setup hits in the last 3 trading days, 3 bullish, 0 bearish, net strength strong.
Review the highest-weight setup hits and confirm with price action before acting.
Total Hits
8
Last 3d
Bullish
3
38% of hits
Bearish
0
0% of hits
Net Bias
Net Bullish
Bullish > Bearish
Top Strength
strong
Weighted strength
Bullish setup hits
Sorted by strength
1d ago
+
RA-Value-IncomeQuality
Bullish screener rule firing in the current setup window.
Strength
High
Weight
64%
Impact
High
Hits
3
+
RA-Quality-LowBeta
Bullish screener rule firing in the current setup window.
Strength
High
Weight
40%
Impact
High
Hits
3
Recent setup history
Date
RA-Value-Dividend
RA-Value-IncomeQuality
RA-Quality-LowBeta
Bullish
Bearish
Total
10.27
Latest
-
1
1
2
0
2
10.26
1d ago
1
1
1
3
0
3
10.25
2d ago
1
1
1
3
0
3
Bullish hitBearish hit- No activity
Open full setup hits view
Setup hits are derived from RankAlpha screener rules firing within the last 3 trading days. Net bias reflects the weighted balance of bullish vs bearish hits.